Abstract
With the growing number of efficient gene therapies on the market, now is the time to take actions to ensure reasonable pricing of gene therapy products. Among these, we propose to incentivize gene therapy companies to adopt a status that translates their corporate social responsibility into concrete commitments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have